by TractManager | Mar 26, 2020 | Emerging Technology Report
Zeposia (ozanimod) is an oral sphingosine-1 phosphate (S1P) receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in...
by TractManager | Mar 23, 2020 | Health Technology Assessment
Focus of the Report: The use of precision pulse capsulotomy (PPC) with the Zepto Capsulotomy System (Mynosys Cellular Devices Inc.) for anterior capsulotomy during cataract surgery in adults.Technology Description: The Zepto Capsulotomy System is a nonlaser,...
by TractManager | Mar 16, 2020 | Health Technology Assessment
Focus of the Report: The use of the AposTherapy System for the treatment of osteoarthritis of the knee (KOA).Technology Description: The AposTherapy device is a foot-worn biomechanical device designed to redistribute the load away from painful areas in the knees,...
by TractManager | Mar 12, 2020 | Health Technology Assessment
Focus of the Report: This report assesses subtalar arthroereisis (SA) for treating adults with symptomatic flatfoot (FF) deformity that does not respond to conservative measures and negatively impacts the patient’s ability to function in activities of daily...
by TractManager | Mar 11, 2020 | Health Technology Assessment
Focus of the Report: This report addressed the use of microfragmented adipose tissue (MFAT) as a stand-alone treatment via intra-articular injection for the treatment of osteoarthritis (OA). Technology Description: To prepare MFAT for use in the joint, fat is...
Recent Comments